Publications by authors named "J Hamley"

Article Synopsis
  • A study in Cameroon linked childhood exposure to the Onchocerca volvulus parasite with an increased risk of developing epilepsy later in life.
  • Researchers incorporated this relationship into an existing model, EPIONCHO-IBM, and simulated the effects of 19 years of ivermectin mass drug administration (MDA) on epilepsy rates.
  • Results showed that in highly endemic areas, 25 years of regular MDA could eliminate onchocerciasis-related epilepsy, emphasizing the need for improved treatment strategies for young children in those regions.
View Article and Find Full Text PDF

Understanding disease transmission in the workplace is essential for protecting workers. To model disease outbreaks, the small populations in many workplaces require that stochastic effects are considered, which results in higher uncertainty. The aim of this study was to quantify and interpret the uncertainty inherent in such circumstances.

View Article and Find Full Text PDF

Aberrant enhancer activation is a key mechanism driving oncogene expression in many cancers. While much is known about the regulation of larger chromosome domains in eukaryotes, the details of enhancer-promoter interactions remain poorly understood. Recent work suggests co-activators like BRD4 and Mediator have little impact on enhancer-promoter interactions.

View Article and Find Full Text PDF

Epidemiological and modelling studies suggest that elimination of transmission (EoT) throughout Africa may not be achievable with annual mass drug administration (MDA) of ivermectin alone, particularly in areas of high endemicity and vector density. Single-dose Phase II and III clinical trials demonstrated moxidectin's superiority over ivermectin for prolonged clearance of microfilariae. We used the stochastic, individual-based EPIONCHO-IBM model to compare the probabilities of reaching EoT between ivermectin and moxidectin MDA for a range of endemicity levels (30 to 70% baseline microfilarial prevalence), treatment frequencies (annual and biannual) and therapeutic coverage/adherence values (65 and 80% of total population, with, respectively, 5 and 1% of systematic non-adherence).

View Article and Find Full Text PDF

Micro Capture-C (MCC) is a chromatin conformation capture (3C) method for visualizing reproducible three-dimensional contacts of specified regions of the genome at base pair resolution. These methods are an established family of techniques that use proximity ligation to assay the topology of chromatin. MCC can generate data at substantially higher resolution than previous techniques through multiple refinements of the 3C method.

View Article and Find Full Text PDF